Sanofi to Acquire Assets from Inhibrx in $2.2 Billion Deal
Sanofi, a leading pharmaceutical company, has announced its plans to purchase assets from biopharmaceutical company Inhibrx in a significant deal ...
Sanofi, a leading pharmaceutical company, has announced its plans to purchase assets from biopharmaceutical company Inhibrx in a significant deal ...